Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas: a randomized study (2024)
- Authors:
- USP affiliated authors: JORGE, RODRIGO - FMRP ; MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP
- Unidade: FMRP
- DOI: 10.1007/s10633-021-09848-6
- Subjects: RETINA; DIABETES MELLITUS; INJEÇÃO; ACUIDADE VISUAL
- Keywords: Photocoagulation; Proliferative diabetic retinopathy; Ranibizumab; Electroretinography
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2024
- Source:
- Título: Documenta Ophthalmologica
- ISSN: 0012-4486
- Volume/Número/Paginação/Ano: v. 143, n. 3, p. 313-322, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
TOSCANO, Luiza et al. Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas: a randomized study. Documenta Ophthalmologica, v. 143, n. 3, p. 313-322, 2024Tradução . . Disponível em: https://doi.org/10.1007/s10633-021-09848-6. Acesso em: 13 fev. 2026. -
APA
Toscano, L., Messias, A. M. V., Messias, K., Lopes, R. de C., Ribeiro, J. A. S., Scott, I. U., & Jorge, R. (2024). Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas: a randomized study. Documenta Ophthalmologica, 143( 3), 313-322. doi:10.1007/s10633-021-09848-6 -
NLM
Toscano L, Messias AMV, Messias K, Lopes R de C, Ribeiro JAS, Scott IU, Jorge R. Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas: a randomized study [Internet]. Documenta Ophthalmologica. 2024 ; 143( 3): 313-322.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s10633-021-09848-6 -
Vancouver
Toscano L, Messias AMV, Messias K, Lopes R de C, Ribeiro JAS, Scott IU, Jorge R. Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas: a randomized study [Internet]. Documenta Ophthalmologica. 2024 ; 143( 3): 313-322.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s10633-021-09848-6 - Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Retinal safety and efficacy of a dexamethasone biodegradable implant to treat macular edema associated to retinal vein occlusion: a phase I/II clinical trial
- Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Intravitreal autologous bone marrow derived stem cells in dry age-related macular degeneration
- Intravitreal autologous bone marrow derived stem cells in ischemic maculopathy
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
Informações sobre o DOI: 10.1007/s10633-021-09848-6 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003212828.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
